Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allurion Technologies (ALUR) Research & Development (2022 - 2025)

Allurion Technologies filings provide 4 years of Research & Development readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 72.56% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.6 million, a 56.41% decrease, with the full-year FY2025 number at $7.6 million, down 56.41% from a year prior.
  • Research & Development hit $1.1 million in Q4 2025 for Allurion Technologies, down from $2.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $7.9 million in Q1 2023 to a low of $1.1 million in Q4 2025.
  • Median Research & Development over the past 4 years was $4.3 million (2024), compared with a mean of $4.4 million.
  • Biggest five-year swings in Research & Development: surged 112.56% in 2023 and later tumbled 72.56% in 2025.
  • Allurion Technologies' Research & Development stood at $5.7 million in 2022, then grew by 5.91% to $6.1 million in 2023, then crashed by 32.1% to $4.1 million in 2024, then tumbled by 72.56% to $1.1 million in 2025.
  • The last three reported values for Research & Development were $1.1 million (Q4 2025), $2.0 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.